Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia
- 20 December 2011
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 59 (2) , 335-338
Abstract
Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder caused by defective glycoprotein, αIIb and β3, encoded by ITGA2B and ITGB3 genes, respectively. We herein describe four unrelated Korean patients with genetically confirmed GT. Two patients were homozygous for c.1913+5G>T (IVS11+5G>T) mutation of ITGB3 with a signature of founder effect. The other two patients were compound heterozygous for two mutations of ITGA2B: c.[2333A>C];[2975delA] (p.[Q778P];[E992Gfs*30]) and c.[1750C>T];[2333A>C] (p.[R584X];[Q778P]). The c.2975delA mutation was a novel frameshift mutation of ITGA2B. Although from a limited number of patients, these results suggests c.1913+5G>T of ITGB3 is a recurrent mutation in Korean patients with GT. Pediatr Blood Cancer 2012;59:335–338.Keywords
This publication has 15 references indexed in Scilit:
- Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse modelsBlood, 2011
- UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosisHaematologica, 2009
- Glanzmann thrombasthenia: the need for epidemiological studiesJournal of Thrombosis and Haemostasis, 2009
- Congenital disorders associated with platelet dysfunctionsThrombosis and Haemostasis, 2008
- Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patientsJournal of Thrombosis and Haemostasis, 2006
- A 13-bp deletion in αIIb gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombastheniaJournal of Thrombosis and Haemostasis, 2005
- Glanzmann's thrombasthenia due to a point mutation within intron 10 results in aberrant splicing of the β3 geneJournal of Thrombosis and Haemostasis, 2003
- A Leu55 to Pro substitution in the integrin αIIb is responsible for a case of Glanzmann's thrombastheniaBritish Journal of Haematology, 2002
- Novel point mutations in the αIIb subunit (Phe289 → Ser, Glu324 → Lys and Gln747 → Pro) causing thrombasthenic phenotypes in four Japanese patientsBritish Journal of Haematology, 1998
- The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.Proceedings of the National Academy of Sciences, 1991